Studies in syngeneic mice indicate rejection of T-cell lymphoma RMA following the inhibition of ERAP1 through a tumor-specific NK cell response due to impaired pMHC class I engagement of Ly49C/I NK cell-inhibitory receptors (66). This evidence concerns the gene ERAP1 and neoplasm.